CBAY Stock Performance and Key Statistics

CBAY has a current P/E ratio of -48.06

The CBAY stock has a trailing twelve month price-to sales (P/S) ratio of 119.98 while its price-to-book (P/B) value is 12.59.

CBAY's price-to-free-cashflow (P/FCF) ratio is -47.07, an indicator that is currently being trending upward.

Based on CBAY's recent bid, its distance from 20 days simple moving average is 0.41%. It is 13.61% apart from 50 days simple moving average, and it is 76.37% apart from 200 days simple moving average.

The 52-week high for CBAY is $32.50 which is -0.06% away from the current price level whereas the distance of that from the 52-week low of $7.26 stands at 347.33%.

The performance of CBAY stock was not encouraging with most of its significant price indicators in green. CymaBay Therapeutics, Inc.(NASDAQ: CBAY) shares have moved upward +0.03% or $0.01 in the latest trading session and have gained 36.33% year-to-date (YTD). The stock has gained nearly 304.02% over the past year. After moving 78.89% over the trailing 3-month period, the stock is 150.58% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 29.01% a week and 35.52% a month.

The current 14-day RSI for CBAY stock is 80.99. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, CymaBay Therapeutics, Inc. (CBAY) has a 14-day ATR of 0.26.

After closing at $32.47 with 114.79M of its shares outstanding, the current enterprise value of CBAY is roughly 3.64B.

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) is up 304.02% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 25.48%. CBAY stock price is also up 36.33% on its value in year-to-date trading.

The number outstanding shares of CBAY is 114.79M, and of these 84.19% shares are freely available for trading. On average, CBAY stock has traded - shares per day for the past 10 days. A total of 8.35M shares changed hands during the last trading session with the average session volume of 3.94M shares.